← Research library

Mexidol and cognitive testing in 90 older adults with chronic cerebral ischemia

Comparison in people · 2026

What was studied
90 adults, mean age 81 ± 3, with chronic cerebral ischemia and cognitive impairment. Standard care plus Mexidol: 43. Standard care alone: 47.
Main finding
At three months, median MMSE was 27 vs 26 points. Schulte test time fell by 8 vs 2 seconds with add-on Mexidol and standard care alone, respectively.

Month 3 · p<0.001

Reported findings and study design

Prospective open comparison with MMSE, Stroop and Schulte testing at baseline and at three months.

Population or model 90 adults, mean age 81 ± 3, with chronic cerebral ischemia and cognitive impairment. Standard care plus Mexidol: 43. Standard care alone: 47.

Dose, route and schedule

Sequential intravenous and oral Mexidol for 74 days, with assessment at three months. The abstract does not specify dose amounts or days on each route.

Protocol source ↗ · Original publisher abstract, group sizes, administration routes and reported cognitive endpoints.

Results · Original publisher abstract, group sizes, administration routes and reported cognitive endpoints.
MeasureResultComparison, timing and statistics
Median MMSE27 vs 26 pointsMonth 3 · p<0.001
Schulte test time−8.0 vs −2.0 secondsReported between-group difference −6.0 seconds (95% CI −9.2 to −2.8)
Stroop words named+7 vs +2 wordsChange intervals 5 to 8 vs 0 to 3 (95% CI)
Mental stability measureNo significant between-group differencep>0.05

Source for these results ↗ · Reviewed 2026-11-15

Study limitations and source details

Study limitations

  • Open prospective comparison. The abstract does not establish randomized allocation, dose amounts, or the clinical importance of the cognitive score differences. This population had chronic ischemia.

Source details

Original publisher abstract, group sizes, administration routes and reported cognitive endpoints.

Sources checked

Citation

Published

Human comparative studyRussian-language source

O. A. Osipova, E. V. Gosteva, U. S. Moskvitina. Mexidol and cognitive testing in 90 older adults with chronic cerebral ischemia Korsakov Journal of Neurology and Psychiatry. 2026;126(9):84–90.

Study source ↗ · DOI 10.17116/jnevro202612609184 · Bibliography entry · Link to this summary

Related compounds

Editorial policy and evidence standards